Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy

被引:33
|
作者
Bijman, Rik G. [1 ]
Breedveld, Sebastiaan [1 ]
Arts, Tine [1 ]
Astreinidou, Eleftheria [2 ]
de Jong, Martin A. [2 ]
Granton, Patrick V. [1 ]
Petit, Steven F. [1 ]
Hoogeman, Mischa S. [1 ]
机构
[1] Erasmus MC Canc Inst, Dept Radiat Oncol, POB 5201, NL-3008 AE Rotterdam, Netherlands
[2] LUMC, Dept Radiat Oncol, Leiden, Netherlands
关键词
COMPLICATION PROBABILITY; SETUP UNCERTAINTIES; RADIOTHERAPY; OPTIMIZATION; HEAD; ROBUSTNESS; RANGE;
D O I
10.1080/0284186X.2017.1355113
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Proton therapy is becoming increasingly available, so it is important to apply objective and individualized patient selection to identify those who are expected to benefit most from proton therapy compared to conventional intensity modulated radiation therapy (IMRT). Comparative treatment planning using normal tissue complication probability (NTCP) evaluation has recently been proposed. This work investigates the impact of NTCP model and dose uncertainties on model-based patient selection. Material and Methods: We used IMRT and intensity modulated proton therapy (IMPT) treatment plans of 78 oropharyngeal cancer patients, which were generated based on automated treatment planning and evaluated based on three published NTCP models. A reduction in NTCP of more than a certain threshold (e.g. 10% lower NTCP) leads to patient selection for IMPT, referred to as 'nominal' selection. To simulate the effect of uncertainties in NTCP-model coefficients (based on reported confidence intervals) and planned doses on the accuracy of model-based patient selection, the Monte Carlo method was used to sample NTCP-model coefficients and doses from a probability distribution centered at their nominal values. Patient selection accuracy within a certain sample was defined as the fraction of patients which had similar selection in both the 'nominal' and 'sampled' scenario. Results: For all three NTCP models, the median patient selection accuracy was found to be above 70% when only NTCP-model uncertainty was considered. Selection accuracy decreased with increasing uncertainty resulting from differences between planned and delivered dose. In case of excessive dose uncertainty, selection accuracy decreased to 60%. Conclusion: Model and dose uncertainty highly influence the accuracy of model-based patient selection for proton therapy. A reduction of NTCP-model uncertainty is necessary to reach more accurate model-based patient selection.
引用
收藏
页码:1444 / 1450
页数:7
相关论文
共 50 条
  • [41] Model-based patterns in prostate cancer mortality worldwide
    Fontes, F.
    Severo, M.
    Castro, C.
    Lourenco, S.
    Gomes, S.
    Botelho, F.
    La Vecchia, C.
    Lunet, N.
    BRITISH JOURNAL OF CANCER, 2013, 108 (11) : 2354 - 2366
  • [42] Mathematical modeling of radiotherapy: impact of model selection on estimating minimum radiation dose for tumor control
    Kutuva, Achyudhan R.
    Caudell, Jimmy J.
    Yamoah, Kosj
    Enderling, Heiko
    Zahid, Mohammad U.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] The relation between prediction model performance measures and patient selection outcomes for proton therapy in head and neck cancer
    Leeuwenberg, Artuur Marijn
    Reitsma, Johannes Bernardus
    van den Bosch, Lisa Griet Lydia Jozef
    Hoogland, Jeroen
    van der Schaaf, Arjen
    Hoebers, Frank Jozef Pieter
    Wijers, Oda Bemadette
    Langendijk, Johannes Albertus
    Moons, Karel Gerardus Maria
    Schuit, Ewoud
    RADIOTHERAPY AND ONCOLOGY, 2023, 179
  • [44] RBE-weighted dose and its impact on the risk of acute coronary event for breast cancer patients treated with intensity modulated proton therapy
    Liu, Chunbo
    Bradley, Julie A.
    Zheng, Dandan
    Vega, Raymond B. Mailhot
    Beltran, Chris J.
    Mendenhall, Nancy
    Liang, Xiaoying
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (04):
  • [45] RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes
    Molinelli, Silvia
    Bonora, Maria
    Magro, Giuseppe
    Casale, Silvia
    Dale, Jon Espen
    Fossati, Piero
    Hasegawa, Azusa
    Mirandola, Alfredo
    Ronchi, Sara
    Russo, Stefania
    Preda, Lorenzo
    Valvo, Francesca
    Orecchia, Roberto
    Ciocca, Mario
    Vischioni, Barbara
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : 227 - 233
  • [46] Model-based selection of the robust JAK-STAT activation mechanism
    Rybinski, Mikolaj
    Gambin, Anna
    JOURNAL OF THEORETICAL BIOLOGY, 2012, 309 : 34 - 46
  • [47] A model-based patient selection tool to identify who may be at risk of exceeding dose tolerances during pancreatic SBRT
    Magallon-Baro, Alba
    Granton, Patrick, V
    Milder, Maaike T. W.
    Loi, Mauro
    Zolnay, Andras G.
    Nuyttens, Joost J.
    Hoogeman, Mischa S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : 116 - 122
  • [48] Deformable image registration uncertainty for inter-fractional dose accumulation of lung cancer proton therapy
    Nenoff, Lena
    Ribeiro, Cassia O.
    Matter, Michael
    Hafner, Luana
    Josipovic, Mirjana
    Langendijk, Johannes A.
    Persson, Gitte F.
    Walser, Marc
    Weber, Damien Charles
    Lomax, Antony John
    Knopf, Antje-Christin
    Albertini, Francesca
    Zhang, Ye
    RADIOTHERAPY AND ONCOLOGY, 2020, 147 : 178 - 185
  • [49] Characterizing decision making under deep uncertainty for model-based energy transitions
    Paredes-Vergara, Matias
    Palma-Behnke, Rodrigo
    Haas, Jannik
    RENEWABLE & SUSTAINABLE ENERGY REVIEWS, 2024, 192
  • [50] Iterative model-based experimental design for efficient uncertainty minimization of chemical mechanisms
    vom Lehn, Florian
    Cai, Liming
    Pitsch, Heinz
    PROCEEDINGS OF THE COMBUSTION INSTITUTE, 2021, 38 (01) : 1033 - 1042